LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

First Add-On Module Automates Cloning of DNA Sequences

By LabMedica International staff writers
Posted on 16 Dec 2015
Image: The BioXp 3200 System (Photo courtesy of Synthetic Genomics Inc. (SGI-DNA Inc.)).
Image: The BioXp 3200 System (Photo courtesy of Synthetic Genomics Inc. (SGI-DNA Inc.)).
The producer of the world's first commercial "DNA printer" is introducing a cloning module that will endow the system with the ability to synthesize and clone custom-designed DNA with an overnight instrument run.

SGI-DNA Inc., a fully owned subsidiary of Synthetic Genomics Inc. (La Jolla, CA, USA) and the manufacturer of the BioXp 3200 System for DNA synthesis, has announced the launch of beta-testing of the BioXp 3200 System Cloning Module.

The benchtop BioXp System is a genomic workstation that generates high-quality DNA from custom designed reagents. Now, with the introduction of the Cloning Module, the BioXp System has the additional capability to assemble and simultaneously deliver up to 24 DNA clones from custom DNA sequences submitted electronically. This module will enable researchers to obtain cloned de novo DNA fragments in their laboratory virtually hands-free, further automating and shortening molecular biology work flows without relying on an external service company.

To synthesis genes on the BioXp system requires custom BioXp reagents. After identifying the desired DNA sequence the researcher uploads a FASTA file to the SGIDNA secure website. The BioXp 3200 System reagents are then manufactured to the researcher's specifications. To begin the assembly reaction, the researcher loads his custom reagents onto the BioXp 3200 deck according to the deck map provided with the reagents. The BioXp connects over the Internet with the cloud to pull down the optimized protocol. The instrument prompts the beginning of the application run. DNA assembly runs generally require 12–17 hours depending on the complexity of the construct.

"It is truly exciting that the technologies we developed for simplifying molecular biology are now being automated by the BioXp System," said Dr. Daniel Gibson, vice president of DNA Technology at SGI-DNA. "The cloning module is very important as it will pave the way to help researchers streamline the study of genes and gene families at an unprecedented rate."

Related Links:

SGI-DNA Inc. (Synthetic Genomics Inc.)


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more